SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope to stop aggressive head & neck Cancer's return
Disease control OngoingThis study is testing whether a one-year course of an immunotherapy drug called pembrolizumab can help prevent cancer from returning in people with high-risk head and neck cancer. About 100 patients who have already finished their main cancer treatment will be randomly assigned t…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 04, 2026 02:21 UTC
-
New drug strategy aims to keep aggressive head and neck cancer at bay
Disease control OngoingThis study is testing if adding the immunotherapy drug pembrolizumab after repeat surgery can help people with recurrent head and neck cancer stay cancer-free for longer. It involves about 45 participants whose cancer has come back in the same area. Some patients will receive the…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Assuntina G. Sacco, MD • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for Tough-to-Treat head and neck cancer
Disease control OngoingThis study is testing if adding an experimental drug called monalizumab to a standard cancer drug (cetuximab) helps people with advanced head and neck cancer live longer. It is for adults whose cancer has returned or spread after trying other treatments, including immunotherapy. …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
First human tests begin for experimental cancer drug targeting multiple tumor types
Disease control OngoingThis early-stage study is testing a new drug called PF-08046052/SGN-EGFRd2 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find the safest dose and understand side effects in 65 participants with specific cancers includin…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New cancer drug shows promise in early human trials
Disease control OngoingThis early-stage trial is testing a new antibody drug called acasunlimab (GEN1046) for people with advanced solid tumors. The study first aims to find safe doses, then tests how well those doses work when given alone or combined with other cancer drugs. All 429 participants will …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Scientists map Cancer's secrets in blood and tumors
Knowledge-focused OngoingThis study aims to understand how certain advanced cancers change during treatment. Researchers will collect blood and tumor samples from 39 patients with specific types of recurrent or metastatic squamous cell cancers (head/neck, esophagus, anal canal) who are starting chemother…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC